Lightcalls.com
 

Fructose is not seldom used as a h...

Fructose is not seldom used as a health subsistence sweetener because the notion that fructose is an acceptable--and healthier--alternative to everyday sugar, or glucose, is quite prevalent in many nutritional circles. however a new study reported in the November 2002 edition of the American Journal of Clinical Nutrition makes an important contribution to growing scientific literature. It confirms fructose is no better for you than glucose--and may unruffled be worse.

The subject of attention indicates that fructose promotes insulin resistance, impaired grape-sugar tolerance, high insulin levels, high triglycerides and high life-current pressure. As with glucose sugar, fructose can increase risk of mark 2 diabetes, the research suggests

if it were not that fructose may pose additional health risks. Fructose, moreover not glucose, is metabolized to fat in the liver. Other hormonal factors glance at that fructose actually promotes disease more readily than grape-sugar That doesn't mean that you Should avoid fruit. Eating whole fruit doesn't provide tremendous amounts of fructose and shouldn't be a question at issue for most people who aren't diabetic or obese. in succession the other hand, everyone should limit his or her intake of fruit juices, sodas and other aliment items that have been sweetened with fructose. This is particularly important for those with high cholesterol plains or insulin resistance, who could be more susceptible to the negative metabolic meanings of fructose.

Americans' consumption of fructose--as a combination of cane-sugar and high-fructose corn syrup--increased by dint of 26 percent from 1970 to 1997 The intake of dietary fructose has increased markedly as a conclusion of the steady addition of added sugars to refined commons products.



The thought was conducted by researchers at the US Department of Agriculture's Western Human Nutrition Research Center and the University of California, the pair in Davis, California, and the Monell Chemical reasons Institute and the University of Pennsylvania, the one and the other in Philadelphia.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.